eNauka - pregled
Pregled prema Autor Novakovic, Tanja
Prikaz rezultata 1 do 13 od 13
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2016 | Addressing challenges for sustainable healthcare in Central and Eastern Europe | Godman, Brian; Novakovic, Tanja; Tesic, Danka; Oortwijn, Wija; Martin, Antony Paul; Parker, Mark; Haycox, Alan | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2018 | Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets | Godman, Brian; ...; Novakovic, Tanja; ...; (broj, koautora 52) | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2019 | Flood Damage Assessment Method: GIS Based Approach | Cosic, Djordje   ; Popov, Srdjan B. ; Novakovic, Tanja; Popovic, Ljiljana M. | Article | 23M23 |
| 2013 | Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia | Medic, G; Baltezarevic, Dragana; Novakovic, Tanja | Conference Paper | Mp. category will be shown later |
| 2021 | Lycopene prevents cisplatin-induced liver tissue damage, without affecting concentrations of TNF-α or iNOS/NO inflammatory pathway | Rankovic, Aleksandar ; Nickovic, Vanja; Novakovic, Tanja; Mitic, Nebojsa; Krdzic, Biljana; Mitic, Jadranka; Nikolic, Gordana; Sokolovic, Dusan | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2013 | Prenatally diagnosed fetal omphalocele at 11 week gestation — a case report | Protrka, Zoran ; Dimitrijevic, Aleksandra ; Kastratovic, Tatjana; Djuric, Janko ; Arsenijević, Petar ; Novakovic, Tanja; Milosavljevic, Milos | Article | Mp. category will be shown later |
| 2019 | Pricing of oral generic cancer medicines in 25 European countries; findings and implications | Godman, Brian; ...; Novakovic, Tanja; Parker, Mark; ...; (broj, koautora 48) | Article | Mp. category will be shown later |
| 2023 | The cost of ischaemic stroke in Croatia | Benkovic, Vanesa; Parker, Mark; Novakovic, Tanja; Mestrovic, Andrija; Budincevic, Hrvoje | Article | 21aM21a |
| 2021 | The Expiry of Humira(R) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures | Moorkens, Evelien; ...; Novakovic, Tanja; ...; (broj, koautora 43) | Article | 21aM21a |
| 2017 | The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications | Ferrario, Alessandra; ...; Novakovic, Tanja; ...; (broj, koautora 24) | Article | 21a+M21a+ |
| 2022 | The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan | Oortwijn, Wija; Surgey, Gavin; Novakovic, Tanja; Baltussen, Rob; Kosherbayeva, Lyazzat | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2017 | The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia | Novakovic, Tanja; Martin, Antony Paul; Parker, Mark; Ferrario, Alessandra; Vukovic, Simo; Landa, Krzysztof; Duba, Jaroslav; Danko, David; Kotsopoulos, Nikolaos; Godman, Brian;
Ristic, Jelena; Stefanovic, Danka; Tesic, Danka;
| Article | 22M22 |
| 2021 | Variation in the prices of oncology medicines across Europe and the implications for the future | Godman, Brian; ...; Novakovic, Tanja; Parker, Mark; ...; (broj, koautora 49) | Article | 23M23 |